OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

Overview

Journal Expert Rev Mol Diagn

Specialty Molecular Biology

Date 2004 Sep 7

PMID 15347252

Citations 17

Authors

Steven J Reynolds

Jeremie Muwonga

Affiliations

Soon will be listed here.

Abstract

Rapid HIV antibody tests represent a key development in the current diagnosis and management of HIV infection. The OraQuick ADVANCE Rapid HIV-1/2 antibody test (OraSure Technologies) has received US Food and Drug Administration approval on the basis of its performance characteristics and a subsequent Clinical Laboratory Improvement Amendments waiver based on its simplicity and accuracy. The test has been approved for use on oral mucosal transudate, whole blood or plasma. Clinical evaluation of the OraQuick ADVANCE Rapid HIV-1/2 antibody test has revealed high sensitivity and specificity. The test has many important applications, extending the opportunities for voluntary counseling and testing, and as a tool for the scale-up of antiretroviral therapy in resource-limited settings.

Citing Articles

Long-acting Injectable PrEP Interest and General PrEP Awareness among People who Inject Drugs in the San Diego-Tijuana Border Metroplex.

Eger W, Bazzi A, Valasek C, Vera C, Harvey-Vera A, Artamonova I AIDS Behav. 2024; 28(5):1650-1661.

PMID: 38319461 PMC: 11549966. DOI: 10.1007/s10461-024-04285-3.

Perceptions and Experiences of Returning Self-collected Specimens for HIV, Bacterial STI and Potential PrEP Adherence Testing among Sexual Minority Men in the United States.

Sharma A, Gandhi M, Sallabank G, Merrill L, Stephenson R AIDS Behav. 2022; 27(4):1091-1105.

PMID: 36094639 PMC: 9466335. DOI: 10.1007/s10461-022-03846-8.

Study Evaluating Self-Collected Specimen Return for HIV, Bacterial STI, and Potential Pre-Exposure Prophylaxis Adherence Testing Among Sexual Minority Men in the United States.

Sharma A, Gandhi M, Sallabank G, Merrill L, Stephenson R Am J Mens Health. 2022; 16(4):15579883221115591.

PMID: 35950608 PMC: 9380227. DOI: 10.1177/15579883221115591.

Evaluation of saliva self-collection devices for SARS-CoV-2 diagnostics.

Allicock O, Petrone M, Yolda-Carr D, Breban M, Walsh H, Watkins A BMC Infect Dis. 2022; 22(1):284.

PMID: 35337266 PMC: 8953967. DOI: 10.1186/s12879-022-07285-7.

Human anti-HIV IgM detection by the OraQuick ® Rapid HIV 1/2 Antibody Test.

Guillon G, Yearwood G, Snipes C, Boschi D, Reed M PeerJ. 2018; 6:e4430.

PMID: 29507828 PMC: 5834934. DOI: 10.7717/peerj.4430.